Phase III Randomized Trial of DFP-10917 vs. Non-Intensive Reinduction LoDAC, Azacitidine or Decitabine +/- Venetoclax or Intensive Reinduction High and Intermediate Dose Cytarabine Regimens for R/R Acute Myelogenous Leukemia Patients in Second, Third or Fourth-Salvage

Brief Summary

Type:
Leukemias

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT03926624

Study #:
STUDY00147087

Start Date:
Aug 17, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03926624

View Complete Trial Details & Eligibility at ClinicalTrials.gov